Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378234776> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W4378234776 abstract "Abstract Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): The Innovation Fund Denmark Background and aims Stroke is a leading cause of mortality and disability, and atrial fibrillation (AF) is an important and potentially modifiable risk factor for stroke. AF screening can substantially increase the amount of patients diagnosed and treated, but randomized trials have yet to demonstrate a significant decrease in strokes following screening. N-terminal prohormone of brain natriuretic peptide (proBNP) is an established biomarker for AF and could potentially be used to select patients for screening. We a used randomized trial of AF screening vs usual care to investigated the usefulness of proBNP as a tool to select patients for screening to prevent outcomes. Methods The LOOP Study randomized AF-naïve individuals aged >70 years with additional stroke risk factors in a 1:3 ratio to either continuous AF screening using implantable loop recorder (ILR) with initiation of anticoagulation upon detection of AF, or usual care. In this post-hoc analysis, study participants with a baseline measurement of proBNP were included, and the effect of screening vs usual care was compared in groups according to proBNP tertiles. Results Of 6004 participants randomized, 5819 (97%) had proBNP measured. The tertiles of proBNP were at <11, 11-22, and 22 pmol/L (Figure 1). A total of 1014 participants (17.4%) were diagnosed with AF (ILR 32.1% vs Control 12.5%), and 310 (5.3%) endured a stroke or systemic arterial embolism (SAE) (ILR 4.5% vs Control 5.6%). In the lower two tertiles of proBNP, 13% were diagnosed with AF (ILR 26.6% vs Control 8.3%), and 4.6% endured a stroke or SAE (ILR 4.6% vs Control 4.6%), whereas in the highest tertile of proBNP, 25.9% were diagnosed with AF (ILR 42.9% vs 20.3%), and 6.73% endured a stroke or SAE (ILR 4.4% vs Control 7.5%). In the lower two tertiles of proBNP, there was no protective effect from AF screening as compared with usual care (hazard ratio (HR) 1.00 (95% CI 0.71-1.41), p=0.999), whereas in the highest tertile of proBNP there was a significant effect of screening (HR 0.59 (95% CI 0.37-0.93), p=0.021) (Figure 2). More details including proBNP cutoffs, and the impact on stroke subtypes, disability and mortality will be presented at the Congress. Conclusions In a population at increased risk of stroke, proBNP pose a useful biomarker to select individuals for AF screening to prevent stroke. In persons with increased proBNP, the effect of screening could be significant, whereas there is no signal towards effects from screening in people with normal proBNP levels." @default.
- W4378234776 created "2023-05-26" @default.
- W4378234776 creator A5011619847 @default.
- W4378234776 creator A5013095733 @default.
- W4378234776 creator A5027418188 @default.
- W4378234776 creator A5041277234 @default.
- W4378234776 creator A5044467554 @default.
- W4378234776 creator A5044965106 @default.
- W4378234776 creator A5057135061 @default.
- W4378234776 creator A5061219595 @default.
- W4378234776 creator A5081108450 @default.
- W4378234776 date "2023-05-24" @default.
- W4378234776 modified "2023-10-16" @default.
- W4378234776 title "Atrial fibrillation screening to prevent stroke in patients with high NT-proBNP - a post-hoc analysis of the randomized LOOP study" @default.
- W4378234776 doi "https://doi.org/10.1093/europace/euad122.061" @default.
- W4378234776 hasPublicationYear "2023" @default.
- W4378234776 type Work @default.
- W4378234776 citedByCount "0" @default.
- W4378234776 crossrefType "journal-article" @default.
- W4378234776 hasAuthorship W4378234776A5011619847 @default.
- W4378234776 hasAuthorship W4378234776A5013095733 @default.
- W4378234776 hasAuthorship W4378234776A5027418188 @default.
- W4378234776 hasAuthorship W4378234776A5041277234 @default.
- W4378234776 hasAuthorship W4378234776A5044467554 @default.
- W4378234776 hasAuthorship W4378234776A5044965106 @default.
- W4378234776 hasAuthorship W4378234776A5057135061 @default.
- W4378234776 hasAuthorship W4378234776A5061219595 @default.
- W4378234776 hasAuthorship W4378234776A5081108450 @default.
- W4378234776 hasBestOaLocation W43782347761 @default.
- W4378234776 hasConcept C126322002 @default.
- W4378234776 hasConcept C127413603 @default.
- W4378234776 hasConcept C164705383 @default.
- W4378234776 hasConcept C168563851 @default.
- W4378234776 hasConcept C177713679 @default.
- W4378234776 hasConcept C185592680 @default.
- W4378234776 hasConcept C187212893 @default.
- W4378234776 hasConcept C2775846464 @default.
- W4378234776 hasConcept C2775915353 @default.
- W4378234776 hasConcept C2778198053 @default.
- W4378234776 hasConcept C2779161974 @default.
- W4378234776 hasConcept C2779751586 @default.
- W4378234776 hasConcept C2780645631 @default.
- W4378234776 hasConcept C2781197716 @default.
- W4378234776 hasConcept C55493867 @default.
- W4378234776 hasConcept C67761136 @default.
- W4378234776 hasConcept C71924100 @default.
- W4378234776 hasConcept C78519656 @default.
- W4378234776 hasConceptScore W4378234776C126322002 @default.
- W4378234776 hasConceptScore W4378234776C127413603 @default.
- W4378234776 hasConceptScore W4378234776C164705383 @default.
- W4378234776 hasConceptScore W4378234776C168563851 @default.
- W4378234776 hasConceptScore W4378234776C177713679 @default.
- W4378234776 hasConceptScore W4378234776C185592680 @default.
- W4378234776 hasConceptScore W4378234776C187212893 @default.
- W4378234776 hasConceptScore W4378234776C2775846464 @default.
- W4378234776 hasConceptScore W4378234776C2775915353 @default.
- W4378234776 hasConceptScore W4378234776C2778198053 @default.
- W4378234776 hasConceptScore W4378234776C2779161974 @default.
- W4378234776 hasConceptScore W4378234776C2779751586 @default.
- W4378234776 hasConceptScore W4378234776C2780645631 @default.
- W4378234776 hasConceptScore W4378234776C2781197716 @default.
- W4378234776 hasConceptScore W4378234776C55493867 @default.
- W4378234776 hasConceptScore W4378234776C67761136 @default.
- W4378234776 hasConceptScore W4378234776C71924100 @default.
- W4378234776 hasConceptScore W4378234776C78519656 @default.
- W4378234776 hasIssue "Supplement_1" @default.
- W4378234776 hasLocation W43782347761 @default.
- W4378234776 hasOpenAccess W4378234776 @default.
- W4378234776 hasPrimaryLocation W43782347761 @default.
- W4378234776 hasRelatedWork W1994785581 @default.
- W4378234776 hasRelatedWork W2008851126 @default.
- W4378234776 hasRelatedWork W2049397185 @default.
- W4378234776 hasRelatedWork W2078437205 @default.
- W4378234776 hasRelatedWork W2125804349 @default.
- W4378234776 hasRelatedWork W2355498105 @default.
- W4378234776 hasRelatedWork W2946283194 @default.
- W4378234776 hasRelatedWork W4286312801 @default.
- W4378234776 hasRelatedWork W4295117803 @default.
- W4378234776 hasRelatedWork W4378234776 @default.
- W4378234776 hasVolume "25" @default.
- W4378234776 isParatext "false" @default.
- W4378234776 isRetracted "false" @default.
- W4378234776 workType "article" @default.